Search: onr:"swepub:oai:DiVA.org:oru-39858" >
The Weighed Core Sy...
The Weighed Core Symptom Scale and Prediction of ADHD in Adults : Objective Measures of Remission and Response to Treatment with Methylphenidate
-
- Edebol, Hanna, 1984- (author)
- Örebro universitet,Institutionen för hälsovetenskap och medicin,Nutrition Gut Brain Interactions Research Centre, Örebro University, Örebro, Sweden
-
- Helldin, Lars (author)
- Department of Psychiatry, NU-Health Care, Trollhättan, Sweden,Department of Psychiatry, the NU-Health Care, Trollhättan
-
- Norlander, Torsten (author)
- Karolinska Institutet
-
(creator_code:org_t)
- Bentham Open, 2013
- 2013
- English.
-
In: Clinical Practice and Epidemiology in Mental Health. - : Bentham Open. - 1745-0179. ; 9, s. 171-179
- Related links:
-
https://doi.org/10.2...
-
show more...
-
http://benthamopen.c...
-
https://kau.diva-por... (primary) (Raw object)
-
https://urn.kb.se/re...
-
https://doi.org/10.2...
-
https://urn.kb.se/re...
-
http://kipublication...
-
show less...
Abstract
Subject headings
Close
- Objective: Two measures of the response rate and the optimal treatment response for adult ADHD were evaluated using methylphenidate. The hypotheses were that Prediction of ADHD (PADHD) defines remission, the Weighed Core Symptom (WCS) scale registers direct effects of medication and that WCS may indicate the optimal dose level during titration.Design: PADHD and WCS were analyzed at baseline and after intake of low doses of either short-acting or modified-release formulations of methylphenidate, MPH (Study I), during titration with modified-release formulations of MPH (18/27, 36, 54, 72 mg) and at three months follow-up (Study II).Patients: Study I consisted of 63 participants (32 females) and Study II consisted of 10 participants (6 females) diagnosed with ADHD and who was to start with treatment.Outcome Measures: Prediction of ADHD (PADHD) indicates the occurrence of ADHD (No, Yes) and the Weighed Core Symptom scale (WCS) quantifies ADHD from 0 to 100 (max-min).Results: The number of clinical cases of ADHD decreased after methylphenidate treatment according to PADHD. WCS increased (p < 0.001) from 9.75 (SD = 12.27) to 47.50 (SD = 29.75) with about 10 mg of methylphenidate (N = 63). During titration, symptoms improved after 18/27 mg and 36 mg of methylphenidate and baseline-follow up comparisons showed WCS increments (p = 0.005) from 31.00 (N = 10, SD = 26.85) to 69.00 (N = 10, SD = 22.34).Conclusions: PADHD defined remission and WCS measured therapeutic effects of methylphenidate in adult ADHD.
Subject headings
- SAMHÄLLSVETENSKAP -- Psykologi (hsv//swe)
- SOCIAL SCIENCES -- Psychology (hsv//eng)
Keyword
- Objective measures
- Weighed Core Symptom scale
- Prediction of ADHD
- remission
- ADHD
- Psychology
- Psykologi
- Psykologi
Publication and Content Type
- ref (subject category)
- art (subject category)
Find in a library
To the university's database